INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Option exercise
M—
40.6K sh
Mar 24, 2026Mar 26, 2026
Page 1060 of 1737
← PrevNext →
traded Mar 24, 2026
+2d
SEC Form 4

Evidence

5
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Option exercise
M—
40.6K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

4
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$243K
41.7K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

3
SG
Samuelson Errol GChief Industry Dev. Officer
ZANDZGZILLOW GROUP, INC.
Grant or award · 10b5-1 plan
A—
7,912 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

3
BA
Balcom AlexandraChief Financial Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
11.4K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

3
BA
Balcom AlexandraChief Financial Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$12K
11.4K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

2
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

2
SP
Soteropoulos PaulaDirector
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M$233K
27.6K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise
M—
212.2K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise
M—
7,188 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Derivative conversion
C—
212.2K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

0
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$21K
5,500 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

0
CC
Chutter Jessica CarolineDirector
PTCTPTC THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
4,000 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

0
CC
Chutter Jessica CarolineDirector
PTCTPTC THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
3,475 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

0
SP
Soteropoulos PaulaDirector
DNTHDianthus Therapeutics, Inc. /DE/
Option exercise · 10b5-1 plan
M—
27.6K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

0
OD
Owens Bradley D.General Counsel
ZANDZGZILLOW GROUP, INC.
Option exercise · 10b5-1 plan
M—
8,800 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

0
CC
Chutter Jessica CarolineDirector
PTCTPTC THERAPEUTICS, INC.
Grant or award · 10b5-1 plan
A—
2,896 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

0
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
5,500 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

56
MP
Menell Richard PeterDirector
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$29K
2,500 sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC Form 4

Evidence

50
AJ
Angotti Vincent J.Director, CHIEF EXECUTIVE OFFICER
TLPHTALPHERA, INC.
Open-market purchase
BUY$125K
213.3K sh
Mar 13, 2026Mar 25, 2026
traded Mar 13, 2026
+12dSEC Form 4

Evidence

47
AM
Angel MatthewDirector, CEO and President, 10% Owner
TPSTTempest Therapeutics, Inc.
Open-market purchase
BUY$500K
231.5K sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC Form 4

Evidence

44
AD
Armstrong Courtney DDirector
VRSNVERISIGN INC/CA
Open-market purchase
BUY$3,980
16 sh
Nov 25, 2025Mar 25, 2026
traded Nov 25, 2025
+120dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
12.6K sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

43
KC
Keyter CharlDirector, Chief Financial Officer
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$95K
35.0K sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

42
PC
Parker Austin ColbyCFO and Treasurer
KYNKayne Anderson Energy Infrastructure Fund, Inc.
Open-market purchase
BUY$36K
2,500 sh
Mar 25, 2026Mar 25, 2026
traded Mar 25, 2026
+0dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$634K
7,749 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$634K
7,749 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$431K
5,140 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$265K
3,162 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$265K
3,162 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

39
SN
Serero Liron NetanelaSee remarks
KLTRKALTURA INC
Open-market purchase
BUY$6,400
5,000 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

39
RC
Rotshten ClaireEVP of Finance
KLTRKALTURA INC
Open-market purchase
BUY$13K
10.0K sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

39
YR
Yekutiel RonDirector, Chief Executive Officer
KLTRKALTURA INC
Open-market purchase
BUY$50K
40.0K sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$99K
1,187 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$131K
1,541 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence